Amongst those was a group of breast cancers with a high proportion of rearrangement signature 3, characterised by small tandem duplications (<10 kb), and immunohistochemically defined as triple-negative breast cancer (TNBC); i.e., lacking expression of ER, PgR, and HER2. The gene discussed is ERBB2; the disease is breast carcinoma.